Elanco Animal Health INC Form 4 insider transactions

Elanco Animal Health Inc. Director R. David Hoover reported a gift of 60,000 shares of common stock to a charitable trust, executed under a Rule 10b5-1 plan.

Elanco Animal Health Inc. Director Lawrence Kurzius purchased 10,000 shares of common stock at $21.30 per share.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired 66.4453 deferred stock units at a price of $21.29 per unit.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 130.0723 deferred stock units, increasing his beneficial ownership in the company.

Elanco Animal Health Inc.'s Executive Vice President, Rajeev A. Modi, purchased 4,500 shares of common stock at $21.33 per share, increasing his direct beneficial ownership to 123,082 shares.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, purchased 6,950 shares of common stock for approximately $150,596 under a Rule 10b5-1 plan.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, purchased 22,000 shares of common stock for approximately $478,495 on December 11, 2025.

Elanco Animal Health Director Stacey Ma was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 119.0047 deferred stock units as part of an executive compensation plan.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 60.7916 deferred stock units at a price of $23.27 per unit.

Elanco Animal Health Inc. director Kapila K. Anand was granted 10,314 deferred stock units as part of an annual equity award.

Elanco Animal Health Director Denise Scots-Knight was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. director Kirk P. McDonald was granted 10,314 deferred stock units as part of an annual equity award for non-employee board members.

Elanco Animal Health Inc. Director Lawrence Kurzius was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. director Deborah Turner Kochevar was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. Director R. David Hoover was granted 10,314 shares of common stock as an annual equity award.

Elanco Animal Health Inc. Director Paul Herendeen was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Director Art A. Garcia was granted 10,314 deferred stock units as part of his annual equity award.

Elanco Animal Health Inc. Director Michael J. Harrington was granted 10,314 deferred stock units as an annual equity award.

Elanco EVP Rajeev A. Modi reported acquiring 67.0754 deferred stock units at $21.09, increasing his DSU holdings to 7,230.2452.

Elanco CEO Jeffrey N. Simmons acquired 131.3058 deferred stock units at $21.09 and now directly holds 18,355.9214 DSUs under the company’s Executive Deferral and Stock Match Plan.

Elanco Animal Health Inc's President and CEO, Jeffrey N. Simmons, acquired 125.0221 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health's EVP, Rajeev A. Modi, reported the acquisition of 63.8655 deferred stock units, effective October 31, 2025, under a Rule 10b5-1 plan.

Jeffrey N. Simmons, Elanco Animal Health's President and CEO, acquired 129.2829 deferred stock units, increasing his total beneficial ownership to 18,099.5935 units.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 66.042 deferred stock units on October 17, 2025, increasing his beneficial ownership to 7,099.3043 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 68.5378 deferred stock units on October 3, 2025.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 134.1686 deferred stock units, increasing his beneficial ownership to 17,970.3106 units.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, was granted 109,857 restricted stock units and 53,869 stock options.

Elanco Animal Health Director Kapila K. Anand deferred cash retainer fees into 428.2522 deferred stock units, increasing her beneficial ownership to 8,513.6102 units.

Jeffrey N. Simmons, Elanco Animal Health's President and CEO, acquired 144.2313 deferred stock units, increasing his total beneficial ownership to 17,836.142 units.